Key result
Olmesartan medoxomil demonstrates significant pleiotropic, cardioprotective, and anti-atherosclerotic effects, including improvement of endothelial function and regression of vascular remodeling.
This review highlights the pleiotropic benefits of olmesartan medoxomil beyond blood pressure lowering, particularly its anti-atherosclerotic properties and ability to reverse vascular remodeling.
Answers are grounded in this paper and cite their sources.
Should not yet change practice; leaves open need for RCTs confirming anti-atherosclerotic outcomes.
The article provides an overview of pleiotropic activity and clinical efficacy of one of the representatives of the class of angiotensin receptor blockers II - olmesartan medoxomil. Analyzed is a wide range of established in experimental and clinical studies and vasoconstriction, cardioprotective, anti-atherogenic, anti-inflammatory and other effects of olmesartan medoxomil. Given clinical studies evaluating anti-atherosclerotic effects of this drug.
No takes yet. Share an insight, caveat, or question.
М. Г. Бубнова (2015) conducted a review in Arterial hypertension and atherosclerosis. Olmesartan medoxomil was evaluated. Olmesartan medoxomil demonstrates significant pleiotropic, cardioprotective, and anti-atherosclerotic effects, including improvement of endothelial function and regression of vascular remodeling.
Synapse has enriched 10 related papers. Consider them for comparative context: